Carl Allen, MD, PhD

Baylor College of Medicine
Houston, TX, United States

Pediatric Hematology/Oncology

Disclosure information not submitted.

Presentation(s):

• 0740: Real-World Demographics, Clinical Characteristics, and Treatment Patterns of Patients Treated with Emapalumab for Secondary Hemophagocytic Lymphohistiocytosis in the United States: The REAL-HLH Study

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time